EXPRESSION OF A 95-KDA MEMBRANE-PROTEIN IS ASSOCIATED WITH LOW DAUNORUBICIN ACCUMULATION IN LEUKEMIC BLAST CELLS

被引:32
作者
DOYLE, LA
ROSS, DD
SRIDHARA, R
FOJO, AT
KAUFMANN, SH
LEE, EJ
SCHIFFER, CA
机构
[1] UNIV MARYLAND,SCH MED,DEPT MED,DIV HEMATOL & ONCOL,BALTIMORE,MD 21201
[2] NCI,MED BRANCH,BETHESDA,MD 20892
[3] JOHNS HOPKINS UNIV,SCH MED,CTR ONCOL,BALTIMORE,MD 21287
关键词
MULTIDRUG RESISTANCE; ANTHRACYCLINE; PROTEIN; ACUTE MYELOID LEUKEMIA;
D O I
10.1038/bjc.1995.11
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 95 kDa membrane protein (P-95) has been previously noted to be overexpressed in a doxorubicin-resistant subline of the MCF-7 breast cancer line and in clinical samples obtained from patients with solid tumours refractory to doxorubicin. We performed Western blotting on blast cell lysates from adults with acute myeloid leukaemia, using antisera to P-95. Concomitant flow cytometric assays measured daunorubicin accumulation and retention. Blasts from 16/46 patient samples had detectable P-95 and had reduced accumulation of daunorubicin compared with the negative marrows. Experiments with the P-95 positive MCF-7 multidrug-resistant subline demonstrated decreased daunorubicin accumulation and retention relative to the sensitive parent line. AML blast cells positive for P-95 also demonstrated greater overall in vitro survival in the presence of daunorubicin relative to the P-95-negative samples. The expression of P-95 did not correlate with failure to achieve an initial complete remission with daunorubicin and cytarabine induction chemotherapy. We conclude that the P-95 protein may possess an efflux transporter function, and may represent another mechanism responsible for anthracycline resistance in acute myeloid leukaemia.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 27 条
[1]  
CHEN YN, 1990, J BIOL CHEM, V265, P10073
[2]   OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE [J].
COLE, SPC ;
BHARDWAJ, G ;
GERLACH, JH ;
MACKIE, JE ;
GRANT, CE ;
ALMQUIST, KC ;
STEWART, AJ ;
KURZ, EU ;
DUNCAN, AMV ;
DEELEY, RG .
SCIENCE, 1992, 258 (5088) :1650-1654
[3]  
DOYLE L, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P237
[4]  
DOYLE LA, 1993, LUNG CANCER, V9, P317
[5]  
FOJO A, 1985, CANCER RES, V45, P3002
[6]  
HALLIGAN BD, 1985, J BIOL CHEM, V260, P2475
[7]  
HAMADA H, 1988, CANCER RES, V48, P7082
[8]  
HIGGINS J, 1992, J BIOENERG BIOMEMBR, V22, P571
[9]  
HWANG JL, 1989, CANCER RES, V49, P958
[10]  
ITO Y, 1989, CANCER, V63, P1534, DOI 10.1002/1097-0142(19890415)63:8<1534::AID-CNCR2820630813>3.0.CO